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ABSTRACT
Diabetes mellitus is a major health care issue affecting thousands of
people each year. As medical research strives for a better understanding of
diabetes, the life expectancy of diabetics is increasing, and the complications
associated with this disease process become more evident. Vascular disease
has specific clinical manifestations as related to diabetes. It is the progression
of arterial insufficiency in the vascular disease of diabetics that will be
discussed in this study. The risk factors identified in diabetic vascular disease
are presented as is their overall effect in the disease process. Current
concepts of noninvasive vascular testing in the diabetic are addressed. The
clinical outcome of the diabetic with vascular disease remains guarded, until
research gains a better understanding of the pathology and the clinical
assessment.

vi

CHAPTER I
INTRODUCTION
Diabetes mellitus is a major health concern to the individual with the
disease and to the health care industry. A great deal of research has been
completed, and is in progress, in search of a cure for diabetes. Although great
strides have been made in the management of diabetes, the numbers afflicted
continue to increase, and the complications from the disease become more
prevalent.
At present, more than 12 million persons are estimated to have diabetes
in the United States. 1 This figure does not include the large percentage that
remain undiagnosed. Depending on the study reporting, diabetes is ranked as
the seventh leading cause of death in Americans. 2 Diabetes is the number one
cause of new cases of blindness and accounts for 50 to 75 percent of all lower
extremity amputations. The estimated medical costs of caring for patients with
diabetes escalates yearly and easily exceeds 20 billion dollars per year.3
The symptoms related to diabetes have been known for centuries and
appear in literature as far back as 1500 B.C. It was not until 1788 that disease
or injury to the pancreas was identified as a factor in diabetes. Diabetes
remained a mystery until the discovery of insulin in 1921.4 At that point, the
medical field gained a new understanding of diabetes, and treatment became
much more sophisticated. Physicians thought that with insulin the disease
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could be controlled, and the diabetic could be expected to live a normal life
span. However, as diabetics lived longer, it became apparent that they were
prone to infections. When antibiotics were developed, it was again felt that
diabetes could be cured with the diabetic leading a normal life. With this
increase in longevity also came the complications of arteriosclerosis and
atherosclerosis which appeared earlier in diabetics and more extensively than in
the general population. 5 ,s The complications from vascular disease became,
and still are, the major cause of morbidity and mortality in the diabetic.
Considering the effects that arterial insufficiency have on the kidney, retina, and
peripheral circulation of diabetic patients, the need to understand the
relationship between diabetes and vascular disease is apparent. Peripheral
vascular disease is a complex disease in itself and becomes more difficult to
assess in combination with diabetes. Many theories have emerged to explain
the increased incidence of vascular disease in diabetics, but several factors
remain uncertain.
Diabetes can present with two distinct forms of vascular disease; namely,
macroangiopathy and microangiopathy? Resulting from thickening and
obstruction of the larger and medium-sized arteries, macroangiopathy is
indistinguishable between diabetics and nondiabetics. Microangiopathy, which
occurs exclusively in diabetics, is a pathologic process in which the capillary
basement membrane becomes thickened. 8 Each diabetic with at least a 20year history of diabetes wi" develop vascular disease. 9 The progression of
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vascular disease in the diabetic is evident as a specific disease process with a
predictable outcome.
Noninvasive vascular studies have become accepted as a reliable source
of pertinent information in the evaluation of arterial circulation. Various methods
have been designed to assess peripheral vascular disease and can be
described as they apply to the diabetic lower extremity. These studies become
essential in documenting the progression of vascular disease in the diabetic.

CHAPTER II
METHODOLOGY
In an extensive literature search, the relationship between. diabetes and
vascular disease is presented in many different aspects. An investigation of the
contrast between diabetic vascular disease and nondiabetic vascular disease
does show a varied disease process. The progression of vascular compromise
in diabetics is defined through various testing procedures as studied in the
literature review. It can also be shown that there is much controversy
surrounding attempts to describe vascular lesions of diabetics. These views
, will
be addressed through a review of literature and described with each stage of
progressive vascular disease in the diabetic.
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CHAPTER III
OVERVIEW OF DIABETES MELLITUS
Diabetes is a disease associated with adverse effects on several systems
within the body. Metabolic, vascular, and neuropathic disorders all contribute to
this complex syndrome. The metabolic component is characterized by
alterations in carbohydrates, fat, and protein metabolism secondary to absent or
markedly diminished insulin secretion or ineffective insulin action. 1 The vascular
component can be shown to exist as abnormalities of both macropathic and
micropathic vessels. The neuropathic factor can be related to both metabolic
and vascular changes.
The classification of diabetes is listed as a class separate from the other
categories of glucose intolerance. Diabetes is then subdivided into four
different types that appear to differ in etiology and pathogenesis. The first type
is Type I or insulin-dependent diabetes with the presence of ketosis. This
signifies the almost complete lack of effective insulin.10 Type II or non-insulindependent diabetes represents 90 percent of the diabetic population. Eighty to
ninety percent of Type II diabetics are obese, which is associated with insulin
resistance. 11 The third type is termed "other" types, which includes several
pancreatic disorders, drug-induced conditions, and hormonal syndromes that
interfere with insulin secretion. 12 Gestational diabetes is listed as the fourth
type.

5

6
Prior to 1979, criteria to diagnose diabetes varied among professionals.
The World Health Organization then established criteria for a diagnosis based
on value of a random, fasting, or oral glucose tolerance test. 13 These levels set
the standard for making a diagnosis of diabetes and establishing protocol for
treatment.
Hyperglycemia becomes the only measurable means for the diabetic to
assess proper control of the disease. The goal for successful treatment would
be maintaining metabolic control by normalizing blood sugars. The diabetic can
remain asymptomatic for years, with proper control, until vascular complications
become evident.
Type I and Type II diabetes are considered separate disease entities,
and therefore are managed differently. Although hyperglycemia occurs in both
Type I and Type II diabetics, the clinical impact is controversial. It should be
noted that Type I diabetics may be more likely to suffer microvascular
complications, whereas Type II diabetics may be more likely to have
macrovascular problems. 14 It is generally agreed that chronic hyperglycemia is
etiologically related to the microvascular complications of diabetes, but it
probably has less effect on atheromatous changes in the larger arteries. 15 The
controversy as to whether proper diabetic control can prevent or avoid vascular
complications is extensively addressed in research data, without specific
consensus.

CHAPTER IV
OVERVIEW OF ATHEROSCLEROSIS
Cardiovascular disease is the chief cause of death in the United States,
and atherosclerosis, the principle cause of myocardial and cerebral infarction,
accounts for the majority of these deaths.16 Atherosclerosis is the leading
cause of chronic lower-extremity ischemia in the majority of patients, even in
those under 40 years of age. 17 Although these facts demonstrate the impact
that atherosclerosis has on health care, research has not been able to
accurately define the cause or describe its pathogenesis.
In an attempt to explain atherosclerosis, arterial lesions have been
studied thoroughly, and many hypotheses have been developed. The
response-to-injury hypothesis, the most widely held current view of
atherogenesis, is that it begins with an injury to the endothelial cell, either from
hemodynamic or toxic factors. 18 With the loss of endothelial cell integrity, there
is increased protein and lipid permeability in the arterial wall with adherence of
platelets to the exposed subendothelial collagen. Platelets release a mitogenic
factor that promotes smooth muscle cell migration and proliferation. This injury,
an atherosclerotic lesion, progresses and may undergo intraplaque hemorrhage
or calcification resulting in the typical atherosclerotic plaque.
The symptoms of lower-extremity arterial insufficiency range from
claudication to tissue necrosis and gangrene. Kannel 19 notes the role of
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intermittent claudication in the overall management of the general
cardiovascular status of an individual. In persons with coronary heart disease,
there is a pronounced increase in risk of claudication. An examination of
survival rates in men and women who developed unequivocal intermittent
claudication, in this study, revealed a high mortality. Ten years after diagnosis,
more than 40 percent of those afflicted, regardless of gender, had died. This
would suggest that intermittent claudication is a lethal phenomenon.
Claudication is often the first sign of peripheral vascular disease, and the
disease process may have been present for years prior to any clinical
symptoms. Claudication is a hallmark of a generally diseased cardiovascular
system, and it is the related cardiovascular impairment which shortens the life
span of the claudication victim. 19
At the cellular and molecular level, research has attempted to identify the
effects that risk factors have on formation and progression of atherosclerosis.
These risk factors include smoking, hypertension, hyperlipoproteinemia, and
diabetes mellitus. 20 In the Framingham Heart StudY,21 cigarette smoking was the
primary risk factor in patients who developed intermittent claudication. Although
studies clearly support the detrimental effects of smoking in vascular disease,
the exact mechanism is unknown. Ritz2 describes three theories that have
been developed to explain how smoking can lead to peripheral vascular
disease. The first theory suggests that increased levels of carboxyhemoglobin
cause a loss of oxygen-carrying capacity, resulting in erythrocythemia and an
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elevated hematocrit. The end result is an increase in blood viscosity and the
formation of a thrombus. The second theory reports that hypoxia of the inner
layers of the arterial wall causes an increase in the permeability of the
endothelium to cholesterol and results in plaque formation. The third
hypothesis relates smoking to platelet abnormalities, which can lead to
thrombus formation. For any or all of these proposed theories, smoking
appears to be an extremely harmful precursor to vascular compromise.
Patients with hypertension have a greater incidence of atherosclerotic
complications than the nonhypertensive population. Hypertension has been
reported to be present in 29 to 39 percent of patients with arteriosclerosis
obliterans. 2o Peripheral vascular disease is twice as common as coronary
artery disease in hypertensive patients. 22 Although the exact effect of
hypertension on the vascular system is unknown, the control of hypertension
does seem to be important in slowing the progression of vascular disease.
Many studies have examined the effect of hypercholesterolemia on
vascular disease. Present studies indicate that control of cholesterol may
reverse early arteriosclerotic vascular disease, but once there is far advanced
disease, the benefit is questionable. 20 Low-density lipoproteins are thought to
contribute to the development of atherosclerosis, while high-density lipoproteins
are probably protective. 23 Measurement of lipid metabolism will need to be
studied in more detail to determine the importance of lipids as a risk factor.
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Diabetes, as a risk factor, combines with vascular disease and presents
as a complex syndrome with a multitude of complications. In research studies,
diabetics are studied independent of nondiabetics in relationship to vascular
disease and other risk factor.

CHAPTER V
DIABETIC VASCULAR DISEASE
Vascular complications appear as the major cause of morbidity and
mortality in diabetic individuals. 24 The vascular disease associated with
diabetes can be subdivided into two general categories: macrovascular disease
affecting the large arteries and clinically presenting as atherosclerosis; and
microvascular disease affecting the small arteries and capillaries, which
clinically presents as diabetic retinopathy and nephropathy, lesions that are
almost unique to individuals with diabetes. 24
Diabetic microangiopathy is a result of metabolic abnormality caused by
an absolute or relative insulin deficiency.2 Research is exploring the effect of
correcting these metabolic abnormalities as a way to prevent or delay the
development of microvascular disease. Data from studies in animals and
humans show that strict diabetic control will ameliorate, possibly prevent, and
even reverse, early microangiopathic changes. 25
Capillary basement membrane thickening is the hallmark of diabetic
microangiopathy.26 Siperstein 27 demonstrated that the protein-based basement
membrane of small blood vessels thickened in patients with diabetes mellitus.
Kil0 28 confirmed this in his study, but also concluded that an association existed
between the duration of diabetes and the degree of thickening. Other studies
have shown that excessive levels of blood sugars can result in the formation of
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glucosylated proteins that resemble the substance responsible for thickening of
the capillary basement membranes seen in diabetics. 4
Other factors may influence microvascular changes, including the aldose
reductase and sorbitol pathways. The overuse of glucose by the sorbitol
pathways in cells that do not require insulin for glucose uptake leads to
intracellular accumulation of sorbitol, which is of potential importance in
producing vascular injury.2 The greater the blood glucose level, the more
sorbitol is formed on the inside of the blood vessels. Aldose reductase, an
enzyme present in most cells, causes the formation of sorbitol inside cells. This
process has severe consequences in the peripheral nerves and leads to the
development of neuropathy, which becomes a critical factor in the rapid
progression of peripheral arterial disease in the diabetic patient. 2
In addition to studies that relate metabolic control to microvascular
changes, other hypotheses have been proposed to explain the preponderance
of vascular disease in diabetics. One hypothesis suggests that there are two
separate and independent genetic traits; one responsible for the biochemical
defect, and the other responsible for vascular disease. 4 Several studies have
shown strong evidence in support of genetic predisposition to diabetes, but
without conclusive results. Another hypothesis proposes an immunologic cause
of diabetic vascular disease because of the resemblance of small vessel
disease in diabetics similar to that observed in patients with various immune
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disorders. 4 Any or perhaps all of these factors may have a role in the
development of microvascular disease and its progression in the diabetic.
Macrovascular complications in diabetics can be described in comparison
to nondiabetics. Lower-extremity arterial occlusive disease is twenty times
more likely to occur in patients with Type" diabetes than in age and sexmatched control subjects. 29 Vascular disease occurs in the diabetic at a much
younger age. Levin30 reported vascular disease development as early as age
forty; the male to female ratio of vascular disease being approximately 2 to 1 in
diabetics compared with 30 to 1 in nondiabetics.
Although the macrovascular lesions of the diabetic and nondiabetic
appear the same, the location of the lesions are variable. Strandness8 found
the pattern of occlusive involvement of the major arteries distinctly different in
the diabetic than in the nondiabetic. He found a higher incidence of
involvement below the knee in the anterior tibial, posterior tibial, and peroneal
arteries of the diabetic. In the diabetic group from the same study, there was
either stenosis or occlusion of 81 percent of the three major vessels below the
knee as compared to 57 percent of these vessels in the nondiabetics. More
evidence comes from surgery cases, as 12 to 17 percent of patients undergoing
aortoiliac reconstruction are diabetic, whereas 65 to 75 percent of patients
undergoing femorotibial bypasses are diabetic. 4 McMillan 31 states that
obstruction below the knee is prominent in diabetics; whereas in nondiabetics,
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the obstruction of arterial flow is principally above the knee. This difference
commonly reduces exercise-associated symptoms in individuals with diabetes.
The existence of occlusive disease with few or no symptoms contributes
to limb loss. According to McMillan,31 blood flow in the skin of the foot has
been known to be increased in diabetics. Nondiabetics have been found to
reduce their blood flow to the skin of their feet by 80 percent when they stand,
but many diabetics cannot do this. During standing, artery-wall motion is
reduced to a minimum because intraluminal arterial pressure in the legs is
raised by gravity. Popliteal artery blood flow is considerably greater in
diabetics, setting the stage for local flow disturbances and atherosclerotic
plaque formation in the branching leg vessels normally protected by low flow.
Risk factors for diabetic vascular disease are essentially the same as for
general vascular disease and include age, smoking, hypertension, and certain
lipoproteins. These factors have an effect on the progression of diabetic
vascular disease, but the severity may differ depending on the type of diabetes
and the number of risk factors present in an individual. Other factors, such as
altered very low density lipoprotein catabolism products, low high density
lipoprotein cholesterol, and high plasma insulin levels have been postulated to
contribute to the excess occurrence of atherosclerosis in diabetics. 32 Any study
of risk factors must include identification of the type of diabetes and method of
management.
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Age is one of the most important risk factors for peripheral vascular
disease in diabetics. 33 Minaker 4 states there is a striking age-related increase
in the prevalence of diagnosed diabetes, undiagnosed diabetes mellitus, and
glucose tolerance. Furthermore, he summarizes in his study that aging and
diabetes express their morbidity through vascular complications, perhaps
through shared and complimentary pathophysiologic mechanisms. In the .
discussion of age as a risk factor, duration of diabetes must be addressed. The
finding of diminished or absent pulses in the lower extremity correlates highly
with duration of diabetes. 33 The duration of diabetes is considered a risk,
regardless of the degree of control, and correlates strongly with the occurrence
of vascular calcification. 35 Severe calcification is twice as common in shortduration diabetes mellitus than in the nondiabetic population and four times as
common in those with long-duration diabetes.5
Smoking, a certain risk factor for atherosclerosis, is even more potent as
a risk factor for the diabetic. In a study of 674 subjects, Beach 36 found a strong
relationship between cigarette smoking and severe arteriosclerosis obliterans.
His study compared types of diabetics and smoking history to severity of
arteriosclerosis obliterans. The diet-treated diabetic who smoked had the
highest prevalence of severe arteriosclerosis obliterans. In another study,
Beach 37 determined that the increased prevalence of detectable arteriosclerosis
obliterans in smokers was highly significant, and evidence of cessation of
smoking was associated with a decrease in the prevalence of arteriosclerosis
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obliterans. Strandness38 found a difference among diabetics treated with diet,
sulfonylurea, or insulin. In the cigarette-smoking diabetic treated by diet, the
prevalence of arterial disease was two and one-half times that of the insulintreated diabetic.
Conflicting data exist on the importance of hypertension as a risk factor in
diabetic vascular disease. Studies indicate that there is an increased
prevalence of hypertension in diabetics. Janka39 showed that peripheral
vascular disease was closely associated with systolic hypertension and with the
duration of diabetes. Laaks040 reported in Finland that diabetic patients had
higher systolic blood pressure and higher frequency of hypertension than
nondiabetic subjects of either sex. In the Framingham studY,33 hypertension
was found to be a risk factor for the appearance of intermittent claudication in
diabetic patients. As these studies indicate, hypertension must be viewed as a
contributing factor in diabetic vascular disease if not a significant independent
factor.
Numerous studies have reviewed the effect of plasma lipids on diabetic
vascular disease, with the three most important being triglycerides,
phospholipids, and cholesterol. 41 The relationship between high levels of low
density lipoprotein (LDL) cholesterol and atherogenesis is generally well
accepted, while high levels of high density lipoprotein (HDL) cholesterol are
believed to be helpful in slowing the process. 5 While this is accepted as a risk
factor for atherosclerosis, the exact relationship to diabetic complication is
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uncertain. Hyperglyceridemia has long been known to be highly prevalent in
the untreated diabetic patient, often accompanied by a decrease in HDL
cholesterol. 41 Uusitupa, et al.,32 in a five-year study of diabetic and nondiabetic
subjects, found HDL cholesterol lower and very-low density lipoprotein (VLDL)
cholesterol higher among diabetic patients. 8each42 found similar results and
determined lipoprotein levels in the diabetics were higher than in an age and
sex-adjusted nondiabetic group. This study divided insulin-dependent and noninsulin-dependent diabetics into separate groups which resulted in several other
differences. VLDL levels were highest in diet-treated subjects followed by
sulfonylurea-treated subjects. VLDL levels in insulin-treated subjects were not
elevated. In a recent study, Taskinen 43 compared insulin-dependent and noninsulin-dependent diabetics and found quantitative abnormalities more common
in the non-insulin-dependent diabetics. The type and management of diabetes
can relate to metabolic control which is another component to hyperlipidemia
research. Feingold44 stated there is a direct relationship between indices of
glycemic control and plasma lipid elevation.
The levels of plasma lipids and their altered states are currently viewed
as one factor in the pathogenesis of diabetic vascular disease. Several
theories have developed to explain the effects of lipoproteins on diabetic
vessels. Virella4s proposed that the increased levels of modified lipoproteins in
diabetic patients may be responsible for the accelerated development of
macrovascular complications associated with the disease. This is thought to
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occur by the ability of modified lipoproteins to induce the transformation of
macrophages into foam cells and to induce endothelial cell damage. More
recently, it was proposed that modified lipoproteins may contribute to
atherogenesis by yet another mechanism; their ability to trigger an immune
response leading to the formation of antibodies and subsequently to the
formation of immune complexes. 46 This process suggests that LDL-immune
complexes may initiate the atherosclerotic process by inducing damage to the
endothelium and contribute to its progression by inducing foam cell formation
and proliferation of smooth muscle cells.
Other factors under review in the pathogenesis of diabetic vascular
disease are platelet function and blood coagulation and deformability.
Winocou~7 noted that platelets from diabetics, compared with those from

nondiabetic subjects, show increased aggregation in response to arachidonate
pathway, collagen, and thrombin; increased granule release; and increased
thromboxane production. This may create mural thrombi, which, if organized,
can incorporate into the vessel wall and further contribute to the atherosclerotic
development. He also suggests that these thrombi may occlude an already
narrowed vessel, or they may break away to lodge elsewhere. Kwaan 48 noted
the many abnormalities in soluble coagulation factors and function that occur in
people with diabetes. He cites the elevation of fibrinogen, which is linked to
platelet aggregation, blood coagulation, blood flow, and atherogenesis.
Ambrus 49 reported the flexibility of normal red blood cell membrane to be
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modified toward inflexibility in a number of diseases, including diabetes. This
creates another factor n the pathogenesis of diabetic vascular disease.
Amputations are often a predictable outcome for many diabetics. The
age-adjusted rate of lower-extremity amputations in the diabetic population is
about 15 times that of the nondiabetic population. 50 Once a limb is amputated,
there is a 30 to 50 percent incidence of gangrene affecting the remaining limb. 6
Jany and Burkus51 reported that after amputation is performed on one leg, the
contralateral extremity will develop ischemic ulceration within 18 to 36 months in
50 percent of these patients. Bell 35 found that vascular changes leading to
gangrene occurred 53 times more frequently in diabetic men and 71 times more
frequently in diabetic women when compared with nondiabetics. These
statistics provide insight into the prognosis for limb loss in the individual with
diabetic vascular disease. Perhaps more significant are the statistics based on
long-term survival following amputation. In the 1970s, studies found a 35
percent mortality in three years and a 59 percent mortality at the end of five
years. By 1984, long-term survival following amputation was still poor, with
studies reporting a 66 percent mortality in two years following amputation.
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CHAPTER VI
CLINICAL ASSESSMENT
The increased incidence and early onset of arterial insufficiency in
diabetics is well-documented. Many adult-onset diabetic patients have evidence
of peripheral vascular disease at the time of diagnosis. 35 Clinical assessment is
important for assessing the diabetic with arterial insufficiency and monitoring the
progress of the disease.
Noninvasive studies have become accepted as a reliable source of
pertinent information in the evaluation of vascular disease. A thorough medical
history and examination become a significant part of noninvasive studies as
certain conditions can cause a miSinterpretation of results. Different testing
procedures may be utilized, depending on the data obtained during the history
taking and physical assessment.
Segmental pressures, one method of noninvasive testing, are used to
study progression of vascular disease, to evaluate medical therapy, to
determine prognosis for healing, and to study prevalence of arterial disease in
population studies. 52 Patients are tested supine with blood pressure cuffs
placed at the proximal thigh, above the knee, below the knee, and at the ankle.
Carter2 explains the rationale of interpreting the various pressure readings.
Starting at the high thigh cuff which determines the aorto-iliac segment, a
pressure of 20 to 30 mmHg above the arm pressure would be considered
20
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normal. Mild gradients of 20 to 3 mmHg lower than arm pressure suggest
stenosis and larger gradients above 30 mmHg suggest arterial occlusion. A
difference between any two levels would indicate vascular insufficiency specific
to the level. Segmental pressures, therefore, reliably localize diseased arterial
segments and correlate with the severity of clinical ischemia.
Several studies, including Piecuch and Jaworski 53 found the resting
ankle/brachial pressure index a simple and valuable method of evaluating blood
supply in the lower extremities. The ankle/brachial systolic pressure ratio or
pressure index is normally always 1.0 or greater. In patients with symptomatic
arterial disease, the pressure index is decreased as the severity of symptoms
increase. 54 In diabetics, however, this index may be falsely raised, probably
due to the presence of medial artery wall calcification. 55 Quigley, et al. 56
determined that diabetic subjects have arteries that are less compressible than
normal arteries, and may make Doppler ankle pressure measurements in
diabetic subjects misleading over the whole range of pressures recorded.
Based on the obseNed occurrence of reamputation in association with normal
or elevated leg/brachial ratios, Emmanuele, et al. 57 found that a Doppler
pressure index above 0.9 is not a reliable indicator of adequate blood flow in
severe diabetic occlusive arterial disease. CarterS determined that the
measurement of systolic pressure at the ankle was helpful in determination of
prognosis in limbs with skin lesions and arterial occlusive disease in the
nondiabetic patient, but was not reliable in the diabetic patient. Goss, et al.
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concluded from their study a high prevalence of raised ankle/brachial pressure
index in insulin-treatment diabetic patients. The increase in the prevalence with
duration of diabetes in the insulin-treated patients is in agreement with the
increase in medial calcification found with increased duration of diabetes. The
presence or severity of peripheral vascular disease may be underestimated in
patients with an obviously raised ankle pressure.
The measurement of toe pressure and the resulting toe/ankle and
toe/brachial pressure indices will identify and quantitate occlusive disease distal
to the ankle. 60 Toe pressures are especially effective in assessing the diabetic
limb. Because 5 to 10 percent of diabetic patients with severe peripheral
vascular disease have markedly elevated ankle pressures due to calcified
vessels,35 toe pressures provide a better assessment when ankle pressures are
falsely elevated. Apelqvist, et al. 61 concluded from his study that a combination
of ankle and toe pressure measurements can be used to predict primary
healing as ankle pressure measurement provided a certain level below which
healing did not occur, and toe pressure measurement revealed an upper level
which did not require amputation. Barnes62 studied noninvasive hemodynamics
on 122 lower-extremity amputations for ischemia. His results determined that
healing of digit or transmetatarsal amputations was influenced by the presence
of diabetes and correlated better with digit pulsation and blood pressure than
with ankle pressure. The frequency of healing in subchronic ulcers with arterial
occlusive disease was correlated with the systolic digital blood pressure and the
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systolic ankle blood pressure in a study by Holstein and Lassen. 63 Their
observations, based on initial pressure measurements in combination with the
final pressure measurements, showed that systolic digital blood pressure is a
particularly valuable prognostic parameter. Data from this study determined no
difference between diabetic and nondiabetic feet as to the healing rates.
With conflicting data based on segmental and toe pressures, particularly
in reference to diabetes, other methods have been applied to assess overall
vascular status. Transcutaneous oxygen pressure (TcP02 ) measurements have
been utilized to select level of amputation and predict wound healing. FalstieJensen, et al. 64 determined transcutaneous oxygen pressure reliable in
assessing optimum level of amputation, and failure rate was unrelated to these
measurements and equal in diabetics and nondiabetics. Burgess, et al. 65
reported that transcutaneous P02 was found to be more consistent with healing
rates in below-knee amputation than Doppler pressures at the ankle for diabetic
patients. Lee, et al.,66 in a study comparing TcP02 and photoplethysmograph to
evaluate the microcirculation status of stumps, found the photoplethysmograph
technique a valuable adjunct in assessing the healing potential after amputation.
Vogelberg and Sauerzweig 67 studied peripheral vascular disease in diabetics
with peripheral pulse deficit. The study detected that the quantitative evaluation
of Doppler velocity measurements seem to be associated with the severity of
peripheral vascular disease, and compared to oscillography offered advantages
in the diagnosis of peripheral vascular disease. In a study comparing various
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methods of noninvasive techniques for effectiveness in predicting amputation
wound healing, a multivariate analysis of determinants was attempted. The
authors concluded from their results that for future assessment of healing and
rehabilitation, a combination of parameters will prove necessary.68 Dependent
on the clinical status and presence or duration of diabetes, these parameters
may include Doppler studies, segmental pressure indices, toe pressures,
photoplethysmography, and transcutaneous P02 measurements.

CHAPTER VII
DISCUSSION
Diabetic vascular disease is difficult to manage as the exact
pathogenesis remains a mystery. Established risk factors, such as
hypertension, smoking, and hyperlipidemia, are known to contribute to the
progression of vascular disease in a diabetic. The controversy on glycemic
control and its role in developing vascular complications becomes another factor
to consider in the management of diabetes. Neuropathy, which is prevalent in
the majority of diabetics to some degree, creates another element of concern to
the diabetic with vascular disease. All these factors need to be addressed
when assessing diabetic vascular disease.
It is estimated that 50 percent of diabetics have evidence of peripheral
vascular disease 10 to 15 years after the onset of diabetes, and 8 percent of
adult diabetics already have peripheral arterial disease at the time their diabetes
is diagnosed. 2 These percentages should alert the diabetic population to the
probability of facing vascular compromise. All forms of impaired glucose
tolerance increase with advancing age; and there is a striking increase in the
incidence of diabetes mellitus with advancing age. 34 These facts should alert
the general population to the possibility of facing vascular compromise.
Diabetics monitor the control of their disease by blood glucose levels,
and many do not seek medical intervention until they develop evidence of

25

26
vascular complications. Foot complications account for more hospital days than
all other diabetic complications combined. 69 The care of foot ulcerations in
diabetics is varied, lengthy, and often unsuccessful, leading to eventual
amputations. The vascular status is crucial through this process, and should be
monitored continually.
Noninvasive testing of arterial flow in lower extremities provides data
needed to establish the viability of a limb or healing potential. The assessment
of any areas of ulceration or necrosis, history of stroke or myocardial infarction,
hypertension, smoking history, and duration and management of diabetes
provides valuable information in addition to the noninvasive studies.
When a diabetic presents with obvious vascular disease, as shown by
clinical assessment, the noninvasive studies, such as segmental pressures or
Doppler waveforms, can be misleading due to noncompressible vessels. The
noncompressible vessel will often have a segmental pressure over 250 mmHg,
but in some diabetic individuals, the pressure may be nearly normal. By clinical
assessment, it will be obvious that diminished arterial flow is evident, but the
vessels may be only partially noncompressible revealing higher pressures than
are actually present. It is difficult, if not impossible, to differentiate between a
normal vessel and a partially noncompressible vessel by segmental pressure or
Doppler waveform. Transcutaneous oxygenation monitoring is helpful in these
cases to provide more insight into actual vascular supply. It then becomes the
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task of the surgeon to interpret the results of these studies with the clinical
picture and elect when to do an amputation.
The progression of vascular disease in a diabetic takes a predestined
course. If a foot ulcer is present, treatment to heal the ulcer will be
administered. Depending on clinical assessment and noninvasive studies,
potential for healing mayor may not be apparent. The diabetic may not seek
medical consultation until the ulcer has been present for some time, or
gangrene has developed. Noninvasive studies and clinical assessment are
essential at this point, not for probability of healing, but to determine level of
amputation. It should be noted that the progression of the disease continues
with statistics as mentioned previously, showing involvement in the contralateral
limb within a few years in the majority of diabetics.
A primary goal in the management of diabetes should be to slow the
progression of vascular disease. This can be accomplished through proper
diabetic teaching. The diabetic must be warned of the severe consequences of
uncontrolled hypertension, smoking, and hyperlipidemia. The diabetic must also
be taught to care for his/her feet and the importance of proper footwear.
Diabetic teaching must be preventative in nature and include the benefits of
exercise.
Exercise has been recommended as part of the protocol in the
management of a diabetic for years. Recently the effects of exercise on
diabetes and its complications have been reexamined?O-72 The beneficial
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effects of exercise on cardiovascular disease in normal subjects apply to
diabetics as well. These benefits might include decreasing VLDL levels, raising
HDL levels, weight loss, and lowering the risk of heart attack. All these factors
are of significance to the diabetic and can alter the rate of progressive vascular
disease.
Other effects of exercise on diabetes have been studied.
Hyperinsulinemia has been associated with atherogenic risk factors in
prediabetic patients; and weight loss and physical activity have been shown to
increase insulin insensitivity and reduce the risk of diabetes. 7o From studies at
the University of California, Forsham71 stated that exercise helps to lower
platelet adhesiveness in diabetics, which may reduce the danger of thrombotic
phenomena. Physical training also seems to improve glycemic control. 72 The
positive impact exercise has on the individual with diabetes reinforces the goal
of incorporating exercise into the management of diabetes.

CHAPTER VIII
CONCLUSION
Diabetic vascular disease is progressive and creates a dismal prognosis
for the individual afflicted. Research has addressed atherosclerosis and
diabetes from many different prospectives, searching for clues to the
pathogenesis of each. The study of lipid metabolism and lipoprotein
modifications has provided insight into atherosclerosis as it relates to diabetes.
The study of platelets and coagulation abnormalities has resulted in a better
understanding of hemodynamics in diabetes and vascular disease. These
findings show progress in research efforts, describing the association between
diabetes and atherosclerosis, but research has made minimal advances in
defining the accelerated rate of vascular disease in the diabetic.
Amputation is an inevitable consequence of diabetic vascular disease,
given sufficient age or duration of diabetes. The reality of this must be
emphasized in diabetic teaching in hopes of reducing noncompliance.
Controlling risk factors and promoting a healthy lifestyle appear to be the best
approach to the overall management of diabetes and vascular disease.
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